A NEW MODEL FOR COLLABORATIVE CLINICAL RESEARCH
IN ONCOLOGY

WE ARE AN INTERNATIONAL, INNOVATIVE, RESEARCH ORGANIZATION IN CLINICAL ONCOLOGY. OUR GOAL IS TO GENERATE THE MOST INNOVATIVE CLINICAL TRIALS WITH THE MOST PROMISING DRUGS BY FOSTERING GLOBAL COLLABORATIONS BETWEEN EXPERT CLINICAL INVESTIGATORS/KOLs AND PHARMACEUTICAL COMPANIES/BIOTECHS.

WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS

MEDSIR IS A PRIVATE COMPANY FOUNDED BY SCIENTIFIC EXPERTS IN 2012. WE ARE DEDICATED TO THE DESIGN AND MANAGEMENT OF STRATEGIC CLINICAL TRIALS IN ONCOLOGY, FROM STUDY CONCEPTION TO THE PUBLICATION OF STUDY RESULTS. OUR INTERNATIONAL TEAM OF HIGH-LEVEL CLINICIANS AND RESEARCH EXPERTS ARE PASSIONATE ABOUT COLLABORATING WITH MEDICAL ONCOLOGISTS AND PHARMACEUTICAL COMPANIES TO DEVELOP THE BEST TREATMENTS FOR PATIENTS AS QUICKLY AS POSSIBLE.

MEDSIR AIMS TO PRESERVE THE VALUE OF SCIENTIFIC KNOWLEDGE BY IMPLEMENTING ORGANIZATIONAL STRUCTURES THAT IMPROVE HUMAN AND ECONOMIC RESOURCE EFFICIENCY, PRODUCING A WIN-WIN FOR ALL PARTIES INVOLVED.

TOGETHER WE BUILD A BRIGHTER FUTURE

2.209

PATIENTS SUCCESSFULLY ENROLLED / LIVES CHANGED

BRING YOUR IDEA TO LIFE

MEDSIR CAN POSITIVELY IMPACT YOUR BUSINESS AT VARIOUS STAGES OF DRUG DEVELOPMENT FOR BOTH BIG PHARMA AND BIOTECHS, WITH OUR PRIMARY FOCUS BEING PRESENT AT THE CRITICAL EARLY STAGES OF DRUG DEVELOPMENT.

20 FUNDERS

>30

TRIALS FUNDED

720 RESEARCHERS

+300

COLLABORATORS

10 MEDICAL MONITORS

LET US HEAR FROM YOU

HAVING A BRIGHT IDEA IS THE FIRST STEP OF A LONG AND COMPLEX PROCESS. IN ORDER FOR YOUR IDEA TO BE TRANSFORMED INTO A WELL-DEVELOPED STUDY PROTOCOL. OUR TEAM WILL DESIGN A CLINICALLY RELEVANT AND STRATEGIC CLINICAL TRIAL. WE WILL THEN FIND THE BEST FUNDING FOR THE TRIAL.